Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-18-073106)

Filing Details

Accession Number:: 0001104659-18-073106
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-14 16:30:29
Reporting Period:: 2018-12-14

Accepted Time:: 2018-12-14 16:30:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720893	Bioxcel Therapeutics Inc.	BTAI	Pharmaceutical Preparations (2834)	821386754

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1733369	Vimal Mehta	C/O Bioxcel Therapeutics, Inc. 555 Long Wharf Drive New Haven CT 06511	Ceo, President, Secretary	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-14	800	$4.27	3,800	No	4	P	Direct
Common Stock	Acquisiton	2018-12-14	200	$4.32	4,000	No	4	P	Direct
Common Stock	Acquisiton	2018-12-14	500	$4.48	4,500	No	4	P	Direct
Common Stock	Acquisiton	2018-12-14	400	$4.49	4,900	No	4	P	Direct
Common Stock	Acquisiton	2018-12-14	100	$4.50	5,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct